<DOC>
	<DOCNO>NCT02597491</DOCNO>
	<brief_summary>In sequential , multiple assignment , randomize trial ( SMART ) current smoker eligible lung cancer screen identify use electronic medical record University Minnesota Minneapolis VA ( N=1000 ) . All participant receive 8 week evidence-based first-line smoking cessation treatment . Participants eligible three potential randomization one year smoking intervention : 1 ) timing identify early response treatment 4 vs. 8 week ( participant ) , 2 ) telephone-based tobacco longitudinal care ( TLC ) vs. TLC plus pharmacist-administered Medication Therapy Management ( incomplete responder first-line treatment , Primary Aim ) , 3 ) monthly TLC contact vs. quarterly TLC contact ( complete responder first-line treatment , Secondary Aim ) . The primary outcome 6 month prolong abstinence measure 18 month begin treatment .</brief_summary>
	<brief_title>SMART Smoking Cessation Lung Cancer Screening</brief_title>
	<detailed_description>In sequential , multiple assignment , randomize trial ( SMART ) current smoker eligible lung cancer screen identify use electronic medical record University Minnesota Minneapolis VA ( N=1000 ) . All participant receive 8 week evidence-based first-line smoking cessation treatment . Participants eligible three potential randomization one year smoking intervention : 1 ) timing identify early response treatment 4 vs. 8 week ( participant ) , 2 ) telephone-based tobacco longitudinal care ( TLC ) vs. TLC plus pharmacist-administered Medication Therapy Management ( incomplete responder first-line treatment , Primary Aim ) , 3 ) monthly TLC contact vs. quarterly TLC contact ( complete responder first-line treatment , Secondary Aim ) . The primary outcome 6 month prolong abstinence measure 18 month begin treatment .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1. schedule low dose CT screening lung cancer , 2. current daily smoker ( eligible smoker smoke past 30 day least 5 past 7 day ; individual make recent quit attempt , example , anticipation low dose CT scan lung cancer screening , eligible last 30 day , smoke regularly , smoke least 5 7 day week ) . 3 . 55 79 year old , 4 . Interested quit willing choose quit smoking date within next 12 week , 5. voluntary write consent 1 . Unstable psychiatric disease , unless stable treatment 3 month ( smoker mental health medication change medication past 3 month require study MD approval participate ) Smokers stable psychiatric disease eligible ; baseline characteristic relate symptom consider analysis , 2 . No hospitalization mental health reason past 3 month ; No thought selfharm past 2 week , 3 . No recent cognitive impairment ( difficulty plan organize daily activity , managing finance , trouble remember appointment , forget correct month year ) , 4 . Participating current smoking cessation treatment ( counsel use NRT , bupropion , varenicline ) , 5 . No phone 6 . NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Smoking ,</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>Sequential , multiple assignment , randomize trial ( SMART )</keyword>
	<keyword>Lung cancer screen</keyword>
</DOC>